search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
OPERATING ROOM


Marketing Associate, B. Braun Interven- tional Systems. “With our products, we aim to manage the risk of bloodstream infections, maintain a sterile field, and reduce waste and control costs by having all components together in one convenient kit.”


Cardinal Health’s needleless cannula technology


“OSHA’s guidance around bloodborne pathogens recommends, ‘When selecting a safer device, [a facility should] identify its intended scope of use in the healthcare facil- ity and any special technique or design fac- tors that will influence its safety, efficiency, and user acceptability,’”10


said Charles Kraft,


RN, Clinical Account Specialist, Acute Clini- cal Products, Cardinal Health. The Cardinal Health Monoject SmarTip needleless cannula addresses all three of these factors: • Clinician safety: Needleless plastic can- nula helps prevent accidental needlesticks.


• Patient safety: Anti-coring design reduces vial coring and the chance of drawing particulate matter along with medication.


 fficiency  g flow rate allows for quick and easy draws, even for viscous fluids


• User acceptability: SmarTip is designed with side aspiration eyelets, which make it easier to access all medication in a vial


without having to manipulate the cannula when drawing up.


IntegriMedical’s needle free injection technology (NFIT)


“Needle free injections technology (NFIT) is the emerging innovation to address the risks associated with needlestick injuries (NSI),” said Lois Wedlock, Director Clini- cal Excellence, Needle Free Solutions and Training. “This technology eliminates all


Cardinal Health Monoject SmarTip needleless cannula


“The new mRNA candidate vaccines


require more force and technique than a needle and syringe can offer. NFIT ensures a consistent dose is administered at the proper depth of penetration every time and reduces the incidence of repetitive stress injury to the healthcare professional. The supply of needles and syringes may be scarce with the expected vaccinations being administered in the coming months and having another option may offer relief to the supply chain.”


“Furthermore, with the current pan- demic, healthcare cannot afford to have distracted workers wondering about their own health status with NSI, whether it be an overworked nurse injecting a patient who accidently gets stuck, to a housekeeper getting stuck from a needle while handling the bed linens,” Wedlock added.


NSI because there is no needle, it is more comfortable to the patient and easy for the healthcare professional to administer the injection. The shields, sheaths and retractors still have a needle; therefore, NSIs can still occur. The NFIT has zero NSI incidents.” Wedlock points out how NFIT technology could help with wide-spread administration of a future COVID-19 vaccination. She states:


Mölnlycke’s double-gloving system “The CDC and OSHA take sharps safety very seriously, yet product selection remains largely the same,” said Lorrie Calabrese, BSN, RN, CNOR, GTS, CCSVP, Clinical Nurse Consultant, Mölnlycke Health Care. “Without new innovations, healthcare must focus on consistent use of available products and best practice.”


Page 42


Veteran Owned • Made in America


drapes • medication labels • surgical markers • urinals • neutral zones


viscotcs@viscot.com • www.viscot.com • 800.221.0658 Our team is standing by to help


viscotcs@viscot.com • www.viscot.com • 800.221.0658


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68